Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell Death Dis. 2014 Apr 10;5:e1155. doi: 10.1038/cddis.2014.122.

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.

Author information

1
1] Department of Stomatology of Nanfang Hospital, Southern Medical University, Guangzhou, PR China [2] Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
2
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
3
1] Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China [2] Department of Pathology, School of Basic Medicine, Guangzhou Medical University, Guangzhou, PR China.

Abstract

It is largely recognized that fibroblast activation protein (FAP) is expressed in cancer-associated fibroblasts (CAFs) of many human carcinomas. Furthermore, FAP was recently also reported to be expressed in carcinoma cells of the breast, stomach, pancreatic ductal adenocarcinoma, colorectum, and uterine cervix. The carcinoma cell expression pattern of FAP has been described in several types of cancers, but the role of FAP in oral squamous cell carcinoma (OSCC) is unknown. The role of endogenous FAP in epithelium-derived tumors and molecular mechanisms has also not been reported. In this study, FAP was found to be expressed in carcinoma cells of OSCC and was upregulated in OSCC tissue samples compared with benign tissue samples using immunohistochemistry. In addition, its expression level was closely correlated with overall survival of patients with OSCC. Silencing FAP inhibited the growth and metastasis of OSCC cells in vitro and in vivo. Mechanistically, knockdown of FAP inactivated PTEN/PI3K/AKT and Ras-ERK and its downstream signaling regulating proliferation, migration, and invasion in OSCC cells, as the inhibitory effects of FAP on the proliferation and metastasis could be rescued by PTEN silencing. Our study suggests that FAP acts as an oncogene and may be a potential therapeutic target for patients with OSCC.

PMID:
24722280
DOI:
10.1038/cddis.2014.122
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center